Adial Pharmaceuticals, Inc. (ADIL)

Adial Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-5.12	-12.73	-19.42	-10.89	-8.59
Depreciation & Amortization	0	0	0.06	0	0
Share-Based Compensation	1.75	3.37	4.24	2.01	1.6
Other Operating Activities	-3.43	-1.83	3.18	1.25	0.65
Operating Cash Flow	-6.81	-11.19	-11.95	-7.63	-6.34
Capital Expenditures	0	0	-0.06	0	0
Acquisitions	1.5	0	0.03	-0.35	0
Investing Cash Flow	1.5	0	-0.03	-0.35	0
Share Issuance / Repurchase	0.75	9.13	13.64	5.61	9.25
Other Financing Activities	3.38	-	-	-	-
Financing Cash Flow	4.13	9.13	13.64	5.61	9.25
Net Cash Flow	-1.17	-2.06	1.66	-2.38	2.91
Free Cash Flow	-6.81	-11.19	-12.01	-7.63	-6.34
Free Cash Flow Per Share	-4.78	-11.17	-16.16	-15.31	-16.08

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).